This invention relates to dihydropyrimidinones of the formula (I), wherein X and R1 to R7 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are BACE2 inhibitors and can be used as medicaments for the treatment or prevention of diseases such as diabetes.
申请公布号
SG175940(A1)
申请公布日期
2011.12.29
申请号
SG20110082062
申请日期
2010.05.05
申请人
F. HOFFMANN-LA ROCHE AG
发明人
BANNER, DAVID;HILPERT, HANS;HUMM, ROLAND;MAUSER, HARALD;MAYWEG, ALEXANDER, V.;RICKLIN, FABIENNE;ROGERS-EVANS, MARK